The PASCAL PLATFORM
With Pascal now a CLIA-cleared platform, it may well be that the sky is the limit for Atomo!
For CLIA wasn’t won on biology alone - it was won on usability:All of that is PASCAL!
- ease of use,
- error rates, and
- performance in untrained hands.
This is more than just validation for one product. It raises the game in a big way.
- Is AT1 simply a supplier, or,
- Is it emerging as a platform for CLIA-enabled diagnostics? And what could those be?
The future looks bright (execution dependent, of-course).
Curious to hear how others see AT1’s role - and how far this could go.
- Forums
- ASX - By Stock
- AT1
- Pascal Passed CLIA - Now What?
AT1
atomo diagnostics limited
Add to My Watchlist
5.88%
!
1.6¢
Pascal Passed CLIA - Now What?
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.